<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03933605</url>
  </required_header>
  <id_info>
    <org_study_id>YUMC 2017-04-030</org_study_id>
    <nct_id>NCT03933605</nct_id>
  </id_info>
  <brief_title>Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy</brief_title>
  <official_title>Comparison of Palonosetron With Combined Palonosetron and Midazolam for Preventing Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yeungnam University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yeungnam University College of Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study, midazolam and palonosetron in combination were more effective than
      palonosetron alone in lowering the incidence and severity of postoperative nausea and
      vomiting in the initial 2 h after laparoscopic cholecystectomy. Postoperative clinical
      complications were not different in both groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 10, 2017</start_date>
  <completion_date type="Actual">February 8, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of postoperative nausea and vomiting</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>0=none; 1=occur</description>
  </primary_outcome>
  <primary_outcome>
    <measure>severity of postoperative nausea and vomiting</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>0 = absent; 1 = mild; 2 = moderate; 3 = severe</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Postoperative Nausea</condition>
  <condition>Postoperative Vomiting</condition>
  <arm_group>
    <arm_group_label>midazolam and palonosetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.05 mg/kg of midazolam i.v. with 0.075 mg of palonosetron i.v. was administered after anesthetic induction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>palonosetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the same volume (0.05 mg/kg) of normal saline i.v. with 0.075 mg of palonosetron i.v. was administered after anesthetic induction</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam and palonosetron group</intervention_name>
    <description>intravenous midazolam and palonosetron administraion as prevention of postoperative nausea and vomiting</description>
    <arm_group_label>midazolam and palonosetron</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>palonosetron group</intervention_name>
    <description>intravenous palonosetron administraion as prevention of postoperative nausea and vomiting</description>
    <arm_group_label>palonosetron</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients (aged 20 to 65 years) scheduled for laparoscopic cholecystectomy with
             American Society of Anesthesiologists (ASA) physical status classification of 1 or 2

        Exclusion Criteria:

          -  The patients with a history of allergy to any other drugs used in this study,
             gastrointestinal disorder, previous PONV, pregnant woman, breastfeeding woman, use of
             antiemetics within 24 hours or body mass index &gt; 30 kg/m2
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eun kyung Choi</name>
      <address>
        <city>Daegu</city>
        <state>Korea (the Republic Of)</state>
        <zip>41944</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 28, 2019</study_first_submitted>
  <study_first_submitted_qc>April 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2019</study_first_posted>
  <last_update_submitted>April 28, 2019</last_update_submitted>
  <last_update_submitted_qc>April 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yeungnam University College of Medicine</investigator_affiliation>
    <investigator_full_name>Eun Kyung Choi</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>postoperative nausea and vomiting</keyword>
  <keyword>midazolam</keyword>
  <keyword>palonosetron</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Palonosetron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

